San Francisco-based Ivivi Health Sciences, the maker of portable electrical stimulation devices for reducing post-operative pain and swelling, said today it has closed on a financing that will bring in $4 million in new capital and convert a $5.5 million bridge loan into an equity stake. The company said it plans to use the money to commercialize its device, develop it for new musculoskeletal uses, and to open a Ivivi Orthopedic Health subsidiary in Seattle.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
